{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:43:41Z","timestamp":1783334621384,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40744-020-00197-5","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T16:02:26Z","timestamp":1581782546000},"page":"301-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Massimo","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ramonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Addimanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Marchesoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73\u201384.","journal-title":"Lancet"},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, et al. The development of assessment of spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u2013883.","journal-title":"Ann Rheum Dis."},{"key":"197_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391.","journal-title":"Ann Rheum Dis."},{"key":"197_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12016-017-8637-0","volume":"55","author":"E Lubrano","year":"2018","unstructured":"Lubrano E, De Socio A, Perrotta FM. Unmet needs in axial spondyloarthritis. Clin Rev Allergy Immunol. 2018;55:332\u20139.","journal-title":"Clin Rev Allergy Immunol."},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/rheumatology\/ket249","volume":"52","author":"A Spadaro","year":"2013","unstructured":"Spadaro A, Lubrano E, Marchesoni A, et al. Remission in ankylosing spondylitis treated with anti-TNF-\u03b1 drugs: a national multicentre study. Rheumatology (Oxford). 2013;52:1914\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3899\/jrheum.140811","volume":"42","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Perrotta FM, Marchesoni A, et al. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-\u03b1 drugs: an Italian multicenter study. J Rheumatol. 2015;42:258\u201363.","journal-title":"J Rheumatol."},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","volume":"74","author":"J Callhoff","year":"2015","unstructured":"Callhoff J, Sieper J, Wei\u00df A, Zink A, Listing J. Efficacy of TNF\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis. 2015;74:1241\u20138.","journal-title":"Ann Rheum Dis."},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","volume":"76","author":"J Braun","year":"2017","unstructured":"Braun J, Baraliakos X, Deodhar A, MEASURE 1 study group, et al. Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Ann Rheum Dis. 2017;76:1070\u20137.","journal-title":"Ann Rheum Dis."},{"key":"197_CR9","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/TCRM.S100091","volume":"12","author":"E Lubrano","year":"2016","unstructured":"Lubrano E, Perrotta FM. Secukinumab for ankylosing spondylitis and psoriatic arthritis. Ther Clin Risk Manag. 2016;12:1587\u201392.","journal-title":"Ther Clin Risk Manag."},{"key":"197_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/ard.2010.147744","volume":"70","author":"N Vastesaeger","year":"2011","unstructured":"Vastesaeger N, van der Heijde D, Inman RD, et al. Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis. 2011;70:973\u201381.","journal-title":"Ann Rheum Dis"},{"key":"197_CR11","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1136\/ard.2007.073098","volume":"67","author":"M Rudwaleit","year":"2008","unstructured":"Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis. 2008;67:1276\u201381.","journal-title":"Ann Rheum Dis."},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3899\/jrheum.17666","volume":"45","author":"E Lubrano","year":"2018","unstructured":"Lubrano E, Perrotta FM, Manara M, et al. The sex influence on response to tumor necrosis factor-\u03b1 inhibitors and remission in axial spondyloarthritis. J Rheumatol. 2018;45:195\u2013201.","journal-title":"J Rheumatol."},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/rheumatology\/kex475","volume":"57","author":"D Poddubnyy","year":"2018","unstructured":"Poddubnyy D, Listing J, Haibel H, Kn\u00fcppel S, Rudwaleit M, Sieper J. Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Rheumatology (Oxford). 2018;57:703\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"197_CR14","first-page":"1694","volume":"21","author":"TR Jenkinson","year":"1994","unstructured":"Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garret SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 1994;21:1694\u20138.","journal-title":"J Rheumatol."},{"key":"197_CR15","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21:2281\u20135.","journal-title":"J Rheumatol."},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden","year":"1984","unstructured":"Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum."},{"key":"197_CR17","first-page":"2286","volume":"21","author":"S Garret","year":"1994","unstructured":"Garret S, Jenkinson T, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286\u201391.","journal-title":"J Rheumatol."},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"JJ Anderson","year":"2001","unstructured":"Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum. 2001;44:1876\u201386.","journal-title":"Arthritis Rheum."},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68:18\u201324.","journal-title":"Ann Rheum Dis."},{"key":"197_CR20","first-page":"951","volume":"26","author":"D Heijde","year":"1999","unstructured":"Heijde D, Calin A, Dougados M, Khan MA, Linden S, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in ankylosing spondylitis. J Rheumatol. 1999;26:951\u20134.","journal-title":"J Rheumatol."},{"key":"197_CR21","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","volume":"56","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Dougados M, Landew\u00e9 R, et al. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology (Oxford). 2017;56:1498\u2013509.","journal-title":"Rheumatology (Oxford)"},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/ard.2011.154799","volume":"71","author":"J Braun","year":"2012","unstructured":"Braun J, Deodhar A, Inman RD, et al. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study. Ann Rheum Dis. 2012;71:661\u20137.","journal-title":"Ann Rheum Dis."},{"key":"197_CR23","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/art.38613","volume":"66","author":"A Molt\u00f3","year":"2014","unstructured":"Molt\u00f3 A, Paternotte S, Claudepierre P, Breban M, Dougados M. Effectiveness of tumor necrosis factor \u03b1 blockers in early axial spondyloarthritis: data from the DESIR cohort. Arthritis Rheumatol. 2014;66:1734\u201344.","journal-title":"Arthritis Rheumatol."},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/ar4244","volume":"15","author":"X Baraliakos","year":"2013","unstructured":"Baraliakos X, Haibel H, Fritz C, Listing J, Heldmann F, Braun J, Sieper J. Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years. Arthritis Res Ther. 2013;15:R67.","journal-title":"Arthritis Res Ther."},{"key":"197_CR25","first-page":"199","volume":"37","author":"F Van den Bosch","year":"2019","unstructured":"Van den Bosch F, Flipo RM, Braun J, Vastesaeger N, Kachroo S, Govoni M. Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study. Clin Exp Rheumatol. 2019;37:199\u2013207.","journal-title":"Clin Exp Rheumatol."},{"key":"197_CR26","unstructured":"Poddubnyy D, Haibel H, Listing J, Braun J, Rudwaleit M, Sieper J. Identification of determinants of the functional outcome in patients with early axial spondyloarthritis: results from the German spondyloarthritis inception cohort 2013 ACR\/ARHP Annual Meeting. 2013."},{"key":"197_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10067-010-1665-2","volume":"30","author":"DU Cansu","year":"2011","unstructured":"Cansu DU, Cal\u0131\u015f\u0131r C, Sava\u015f Yava\u015f U, Ka\u015fifo\u011flu T, Korkmaz C. Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis. Clin Rheumatol. 2011;30:557\u201362.","journal-title":"Clin Rheumatol."}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-020-00197-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T17:22:14Z","timestamp":1715188934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-020-00197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1007\/s40744-020-00197-5","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}